Locus Pharma Raises $30.2 Million

Locus Pharmaceuticals Inc., a Blue Bell, Pa.-based small-molecule drug developer, has raised $30.2 million in fifth-round funding. Novartis Bioventures Ltd., HBM BioVentures and return backer Prism VentureWorks co-led the deal, and were joined by existing shareholders S.R. One Ltd. and L Capital Partners. The company has now raised around $122 million in total VC funding since 1999, including a $40 million Series D round in 2001 at a post-money valuation of approximately $196 million.